期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Wilson's disease: A review of what we have learned 被引量:10
1
作者 Kryssia Isabel Rodriguez-Castro Francisco Javier Hevia-Urrutia Giacomo Carlo Sturniolo 《World Journal of Hepatology》 CAS 2015年第29期2859-2870,共12页
Wilson's disease(WD), which results from the defective ATP7 B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic fail... Wilson's disease(WD), which results from the defective ATP7 B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury. 展开更多
关键词 Wilson's DISEASE WILSON DISEASE chelatingagents PENICILLAMINE Zinc Copper ORPHAN DISEASE Liver TRANSPLANTATION
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部